Are proteinases the reason for keratoconus

Current Eye Research

Volumn 35, Issue 3, 2010, Pages 185-191

  Balasubramanian, Sivaraman A ^a   Pye, David C ^a   Willcox, Mark D P ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Cathepsin; Cytokine; Keratoconus; Matrix metalloproteinase; Proteases

Indexed keywords

ASPARTIC ACID; CATHEPSIN B; CATHEPSIN G; CATHEPSIN K; COLLAGENASE; COLLAGENASE 3; CYSTEINE; CYTOKINE; GELATINASE; GELATINASE A; GELATINASE B; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; PROTEINASE; RIBOFLAVIN; STROMELYSIN; STROMELYSIN 2; STROMELYSIN 3; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ATOPY; COLLAGEN DEGRADATION; CONTACT LENS; CYTOKINE RELEASE; DISEASE COURSE; DOWN SYNDROME; EHLERS DANLOS SYNDROME; ENZYME ACTIVATION; ENZYME SYNTHESIS; GENE OVEREXPRESSION; GENETIC DISORDER; HUMAN; INFLAMMATION; KERATOCONUS; MARFAN SYNDROME; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHORT SURVEY; ULTRAVIOLET A RADIATION;

CATHEPSINS; COLLAGEN; CORNEAL STROMA; HUMANS; KERATOCONUS; MATRIX METALLOPROTEINASES; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 77950801507     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713680903477824     Document Type: Short Survey

References (90)

1. Rabinowitz YS. Keratoconus. Surv Ophthalmol. 1998;42: 297-319
2. Dastjerdi MH, Hashemi H. A quantitative corneal topography index for detection of keratoconus. J Refract Surg. 1998;14:427-436 (Pubitemid 28350707)
3. Suzuki M, Amano S, Honda N, et al. Longitudinal changes in corneal irregular astigmatism and visual acuity in eyes with keratoconus. Jpn J Ophthalmol. 2007;51:265-269 (Pubitemid 47174611)
4. Lema I, Duran JA. Inflammatory molecules in the tears of patients with keratoconus. Ophthalmology. 2005;112:654-659 (Pubitemid 41108867)
5. Lema I, Sobrino T, Duran JA, et al. Subclinical keratoconus and inflammatory molecules from tears. Br J Ophthalmol. 2009;93:820-824
6. Jacq PL, Sale Y, Cochener B, et al. Keratoconus, changes in corneal topography and allergy. Study of 3 groups of patients. J Fr Ophtalmol. 1997;20:97-102 (Pubitemid 27104137)
7. Gasset AR, Houde WL, Garcia-Bengochea M. Hard contact lens wear as an environmental risk in keratoconus. Am J Ophthalmol. 1978;85:339-341 (Pubitemid 8313833)
8. Bawazeer AM, Hodge WG, Lorimer B. Atopy and keratoconus: A multivariate analysis. Br J Ophthalmol. 2000;84: 834-836 (Pubitemid 30599086)
9. Cullen JF, Butler HG. Mongolism (Down's syndrome) and keratoconus. Br J Ophthalmol. 1963;47:321-330
10. Pearson AR, Soneji B, Sarvananthan N, et al. Does ethnic origin influence the incidence or severity of keratoconus? Eye. 2000;14(Pt 4):625-628
11. Georgiou T, Funnell CL, Cassels-Brown A, et al. Influence of ethnic origin on the incidence of keratoconus and associated atopic disease in Asians and white patients. Eye. 2004;18:379-383 (Pubitemid 38585012)
12. Heverly VL, Lowther G, Epidemiology of keratoconus. Retrieved from Last accessed 18 July 2009
13. Fink BA, Wagner H, Steger-May K, et al. Differences in keratoconus as a function of gender. Am J Ophthalmol. 2005;140:459-468
14. Ertan A, Muftuoglu O. Keratoconus clinical findings according to different age and gender groups. Cornea. 2008;27: 1109-1113
15. Krachmer JH, Feder RS, Belin MW. Keratoconus and related noninflammatory corneal thinning disorders. Surv Ophthalmol. 1984;28:293-322
16. Bron AJ. Keratoconus. Cornea. 1988;7:163-169
17. Cristina Kenney M, Brown DJ. The cascade hypothesis of keratoconus. Cont Lens Anterior Eye. 2003;26:139-146
18. Collier SA. Is the corneal degradation in keratoconus caused by matrix-metalloproteinases? Clin Experiment Ophthalmol. 2001;29:340-344
19. Critchfield JW, Calandra AJ, Nesburn AB, et al. Keratoconus: I. Biochemical studies. Exp Eye Res. 1988;46:953-963
20. Nagase H, Woessner JF, Jr. Matrix metalloproteinases. J Biol Chem. 1999;274:21491-21494 (Pubitemid 129519680)
21. Harper E, Bloch KJ, Gross J. The zymogen of tadpole collagenase. Biochemistry. 1971;10:3035-3041
22. Murphy G, Stanton H, Cowell S, et al. Mechanisms for pro matrix metalloproteinase activation. APMIS. 1999;107: 38-44 (Pubitemid 29133521)
23. Murphy GJ, Murphy G, Reynolds JJ. The origin of matrix metalloproteinases and their familial relationships. FEBS Lett. 1991;289:4-7
24. Hanemaaijer R, Visser H, Koolwijk P, et al. Inhibition of MMP synthesis by doxycycline and chemically modified tetracyclines (CMTs) in human endothelial cells. Adv Dent Res. 1998;12:114-118
25. Fini ME, Cook JR, Mohan R. Proteolytic mechanisms in corneal ulceration and repair. Arch Dermatol Res. 1998;290: S12-S23
26. Bode W, Fernandez-Catalan C, Grams F, et al. Insights into MMP-TIMP interactions. Ann N Y Acad Sci. 1999;878:73-91 (Pubitemid 29353561)
27. Murphy G, Nagase H. Progress in matrix metalloproteinase research. Mol Aspects Med. 2008;29:290-308
28. Nagase H, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res. 2006;69:562-573 (Pubitemid 43139720)
29. Woessner JF, Jr. MMPs and TIMPs-An historical perspective. Mol Biotechnol. 2002;22:33-49
30. Kaos WW, Vergnes JP, Ebert J, et al. Increased collagenase and gelatinase activities in keratoconus. Biochem Biophys Res Commun. 1982;107:929-936 (Pubitemid 13207676)
31. Rehany U, Lahav M, Shoshan S. Collagenolytic activity in keratoconus. Ann Ophthalmol. 1982;14:751-754 (Pubitemid 12047009)
32. Kenney MC, Chwa M, Escobar M, et al. Altered gelatinolytic activity by keratoconus corneal cells. Biochem Biophys Res Commun. 1989;161:353-357 (Pubitemid 19153966)
33. Fini ME, Yue BY, Sugar J. Collagenolytic/gelatinolytic metalloproteinases in normal and keratoconus corneas. Curr Eye Res. 1992;11:849-862
34. Zhou L, Sawaguchi S, Twining SS, et al. Expression of degradative enzymes and protease inhibitors in corneas with keratoconus. Invest Ophthalmol Vis Sci. 1998;39: 1117-1124 (Pubitemid 28247345)
35. Kenney MC, Chwa M, Opbroek AJ, et al. Increased gelatinolytic activity in keratoconus keratocyte cultures. A correlation to an altered matrix metalloproteinase-2/tissue inhibitor of metalloproteinase ratio. Cornea. 1994;13:114-124 (Pubitemid 24083047)
36. Smith VA, Matthews FJ, Majid MA, et al. Keratoconus: Matrix metalloproteinase-2 activation and TIMP modulation. Biochim Biophys Acta. 2006;1762:431-439
37. Kenney MC, Chwa M, Alba A, et al. Localization of TIMP-1, TIMP-2, TIMP-3, gelatinase A and gelatinase B in pathological human corneas. Curr Eye Res. 1998;17:238-246 (Pubitemid 28138270)
38. Matthews FJ, Cook SD, Majid MA, et al. Changes in the balance of the tissue inhibitor of matrix metalloproteinases (TIMPs)-1 and -3 may promote keratocyte apoptosis in keratoconus. Exp Eye Res. 2007;84:1125-1134
39. Kim WJ, Rabinowitz YS, Meisler DM, et al. Keratocyte apoptosis associated with keratoconus. Exp Eye Res. 1999;69: 475-481
40. Kaldawy RM, Wagner J, Ching S, et al. Evidence of apoptotic cell death in keratoconus. Cornea. 2002;21:206-209 (Pubitemid 34188793)
41. Alexander CM, Werb Z. Proteinases and extracellular matrix remodeling. Curr Opin Cell Biol. 1989;1:974-982 (Pubitemid 20044899)
42. Collier SA, Madigan MC, Penfold PL. Expression of membrane- type 1 matrix metalloproteinase (MT1-MMP) and MMP-2 in normal and keratoconus corneas. Curr Eye Res. 2000;21:662-668
43. Murphy G, Willenbrock F, Crabbe T, et al. Regulation of matrix metalloproteinase activity. Ann N Y Acad Sci. 1994;732:31-41
44. Sato H, Takino T, Okada Y, et al. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature. 1994;370:61-65 (Pubitemid 24216953)
45. Stronglin AY, Collier Y, Bannikov G, et al. Mechanism of cell surface activation of 72-kDa type IV collagenase. J Biol Chem. 1995;270:5331-5338
46. Ohuchi E, Imai K, Fujii Y, et al. Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem. 1997;272: 2446-2451 (Pubitemid 27058534)
47. Heusel JW, Hanson RD, Silverman GA, et al. Structure and expression of a cluster of human hematopoietic serine protease genes found on chromosome 14q11.2. J Biol Chem. 1991;266:6152-6158
48. Chwieralski CE, Welte T, Buhling F. Cathepsin-regulated apoptosis. Apoptosis. 2006;11:143-149 (Pubitemid 43291015)
49. Elliot S, Catanuto P, Marin-Castano ME, et al. RPE express MT1-MMP and its levels are regulated by estrogen and oxidant injury. Invest Ophthalmol Vis Sci. 2003;44:E-Abstract 478
50. Grandas OH, Mountain DJ, Kirkpatrick SS, et al. Effect of hormones on matrix metalloproteinases gene regulation in human aortic smooth muscle cells. J Surg Res. 2008;148: 94-99
51. Spoerl E, Zubaty V, Raiskup-Wolf F, et al. Oestrogen-induced changes in biomechanics in the cornea as a possible reason for keratectasia. Br J Ophthalmol. 2007;91:1547-1550 (Pubitemid 350044064)
52. Suzuki T, Sullivan DA. Estrogen stimulation of proinflammatory cytokine and matrix metalloproteinase gene expression in human corneal epithelial cells. Cornea. 2005;24:1004-1009 (Pubitemid 41688540)
53. Skrzydlewska E, Sulkowska M, Koda M, et al. Proteolyticantiproteolytic balance and its regulation in carcinogenesis. World J Gastroenterol. 2005;11:1251-1266 (Pubitemid 40425906)
54. Turk B, Turk D, Turk V. Lysosomal cysteine proteases: More than scavengers. Biochim Biophys Acta. 2000;1477:98-111 (Pubitemid 30119895)
55. Mohamed MM, Sloane BF. Cysteine cathepsins: Multifunctional enzymes in cancer. Nat Rev Cancer. 2006;6: 764-775
56. Whitelock RB, Fukuchi T, Zhou L, et al. Cathepsin G, acid phosphatase, and alpha 1-proteinase inhibitor messenger RNA levels in keratoconus corneas. Invest Ophthalmol Vis Sci. 1997;38:529-534
57. Haeckel C, Krueger S, Buehling F, et al. Expression of cathepsin K in the human embryo and fetus. Dev Dyn. 1999;216:89-95
58. Mackiewicz Z, Maatta M, Stenman M, et al. Collagenolytic proteinases in keratoconus. Cornea. 2006;25:603-610 (Pubitemid 44620108)
59. Chwa M, Atilano SR, Hertzog D, et al. Hypersensitive response to oxidative stress in keratoconus corneal fibroblasts. Invest Ophthalmol Vis Sci. 2008;49:4361-4369
60. Im E, Kazlauskas A. The role of cathepsins in ocular physiology and pathology. Exp Eye Res. 2007;84:383-388 (Pubitemid 46204684)
61. Neurath H, Walsh KA. Role of proteolytic enzymes in biological regulation (a review). Proc Natl Acad Sci U S A. 1976;73:3825-3832
62. Berquin IM, Sloane BF. Cathepsin B expression in human tumors. Adv Exp Med Biol. 1996;389:281-294 (Pubitemid 26149760)
63. Whitelock RB, Li Y, Zhou LL, et al. Expression of transcription factors in keratoconus, a cornea-thinning disease. Biochem Biophys Res Commun. 1997;235:253-258 (Pubitemid 27302721)
64. Wilson SE, He YG, Weng J, et al. Epithelial injury induces keratocyte apoptosis: Hypothesized role for the interleukin- 1 system in the modulation of corneal tissue organization and wound healing. Exp Eye Res 1996;62:325-327 (Pubitemid 26151425)
65. Fabre EJ, Bureau J, Pouliquen Y, et al. Binding sites for human interleukin 1 alpha, gamma interferon and tumor necrosis factor on cultured fibroblasts of normal cornea and keratoconus. Curr Eye Res. 1991;10:585-592
66. Zhou L, Whitelock RB, Yue BYJT, et al. Cytokine and receptor expression in keratoconus corneas. Invest Ophthalmol Vis Sci. 1996;37:S1017 (Pubitemid 126826147)
67. Kim SH, Mok JW, Kim HS, et al. Association of -31T>C and -511 C>T polymorphisms in the interleukin 1 beta (IL1B) promoter in Korean keratoconus patients. Mol Vis. 2008;14:2109-2116
68. Cox SW, Eley BM, Kiili M, et al. Collagen degradation by interleukin-1beta-stimulated gingival fibroblasts is accompanied by release and activation of multiple matrix metalloproteinases and cysteine proteinases. Oral Dis. 2006;12:34-40
69. Xue ML, Wakefield D, Willcox MD, et al. Regulation of MMPs and TIMPs by IL-1beta during corneal ulceration and infection. Invest Ophthalmol Vis Sci. 2003;44: 2020-2025 (Pubitemid 36520295)
70. Li DQ, Lokeshwar BL, Solomon A, et al. Regulation of MMP-9 production by human corneal epithelial cells. Exp Eye Res. 2001;73:449-459 (Pubitemid 33078221)
71. Kim HS, Shang T, Chen Z, et al. TGF-beta1 stimulates production of gelatinase (MMP-9), collagenases (MMP-1, -13) and stromelysins (MMP-3, -10, -11) by human corneal epithelial cells. Exp Eye Res. 2004;79:263-274 (Pubitemid 39119415)
72. Zhou L, Yue BY, Twining SS, et al. Expression of wound healing and stress-related proteins in keratoconus corneas. Curr Eye Res. 1996;15:1124-1131 (Pubitemid 26395271)
73. Maier P, Broszinski A, Heizmann U, et al. Active transforming growth factor-beta2 is increased in the aqueous humor of keratoconus patients. Mol Vis. 2007;13:1198-1202 (Pubitemid 47091362)
74. Saghizadeh M, Brown DJ, Castellon R, et al. Overexpression of matrix metalloproteinase-10 and matrix metalloproteinase- 3 in human diabetic corneas: A possible mechanism of basement membrane and integrin alterations. Am J Pathol. 2001;158:723-734 (Pubitemid 32158634)
75. Seppala HP, Maatta M, Rautia M, et al. EMMPRIN and MMP-1 in keratoconus. Cornea. 2006;25:325-330
76. Caroline P, Andre M, Kinoshita B, et al. Etiology, diagnosis, and management of keratoconus: New thoughts and new understandings. Retrieved from. Last accessed 15 April 2009
77. Nottingham J. Practical Observations on Conical Cornea: And on the Short Sight, and Other Defects of Vision Connected with It. London: J. Churchill, 1854
78. Parker J, Ko WW, Pavlopoulos G, et al. Videokeratography of keratoconus in monozygotic twins. J Refract Surg. 1996;12:180-183 (Pubitemid 26051475)
79. Francois J. Heredity in Ophthalmology. St. Louis: CV Mosby, 1961
80. Bisceglia L, De Bonis P, Pizzicoli C, et al. Linkage analysis in keratoconus: Replication of locus 5q21.2 and identification of other suggestive loci. Invest Ophthalmol Vis Sci. 2009;50:1081-1086
81. Wang Y, Rabinowitz YS, Rotter JI, et al. Genetic epidemiological study of keratoconus: Evidence for major gene determination. Am J Med Genet. 2000;93:403-409 (Pubitemid 30622187)
82. Edwards M, McGhee CN, Dean S. The genetics of keratoconus. Clin Experiment Ophthalmol. 2001;29:345-351 (Pubitemid 34036733)
83. Shoji J, Kawaguchi A, Gotoh A, et al. Concentration of soluble interleukin-6 receptors in tears of allergic conjunctival disease patients. Jpn J Ophthalmol. 2007;51:332-337 (Pubitemid 47561672)
84. Leonardi A, Brun P, Abatangelo G, et al. Tear levels and activity of matrix metalloproteinase (MMP)-1 and MMP-9 in vernal keratoconjunctivitis. Invest Ophthalmol Vis Sci. 2003;44:3052-3058 (Pubitemid 36759772)
85. Maatta M, Kari O, Tervahartiala T, et al. Elevated expression and activation of matrix metalloproteinase 8 in tear fluid in atopic blepharoconjunctivitis. Cornea. 2008;27:297-301 (Pubitemid 351440862)
86. Schultz CL, Kunert KS. Interleukin-6 levels in tears of contact lens wearers. J Interferon Cytokine Res. 2000;20: 309-310 (Pubitemid 30169742)
87. Bureau J, Fabre EJ, Hecquet C, et al. Modification of prostaglandin E2 and collagen synthesis in keratoconus fibroblasts, associated with an increase of interleukin 1 alpha receptor number.C R Acad Sci III. 1993;316:425-430 (Pubitemid 23186427)
88. Kamolmatyakul S, Chen W, Yang S, et al. IL-1alpha stimulates cathepsin K expression in osteoclasts via the tyrosine kinase-NF-kappaB pathway. J Dent Res. 2004;83:791-796 (Pubitemid 41766161)
89. Meijers MHM, Aisa CM, Billingham MEJ, et al. The effect of interleukin-1β and transforming growth factor β on cathepsin B activity in human articular chondrocytes. Inflammation Res. 1994;41:C198-C200 (Pubitemid 24257894)
90. Wollensak G, Spoerl E, Seiler T. Riboflavin/ultravioleta- induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003;135:620-627 (Pubitemid 36457967)